Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Kcna2em1/Cya
Common Name:
Kcna2-KO
Product ID:
S-KO-02733
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Kcna2-KO
Strain ID
KOCMP-16490-Kcna2-B6J-VA
Gene Name
Kcna2
Product ID
S-KO-02733
Gene Alias
Akr6a4; Gm10672; Kca1-2; Kv1.2; Mk-2
Background
C57BL/6JCya
NCBI ID
16490
Modification
Conventional knockout
Chromosome
3
Phenotype
MGI:96659
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Kcna2em1/Cya mice (Catalog S-KO-02733) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000038695
NCBI RefSeq
NM_008417
Target Region
Exon 3
Size of Effective Region
~2.2 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Kcna2, encoding the Kv1.2 potassium voltage-gated channel subunit, is highly expressed in the central and peripheral nervous systems [1]. Kv1.2 channels regulate neuronal excitability, playing a crucial role in the electrical activity of neurons [3]. They are directly involved in the mechanisms related to various neurological functions and diseases [4]. Genetic models, such as gene knockout (KO) or conditional knockout (CKO) mouse models, can be valuable for studying Kcna2's functions.

Functional studies using a Xenopus oocyte two-microelectrode voltage-clamp system on patients with Kcna2 mutations showed that different types of mutations (loss-of-function, gain-of-function, and gain-and-loss-of-function) led to distinct phenotypic features in epileptic encephalopathy. Loss-of-function mutations were associated with predominant focal seizures and prominent sleep-activated epileptic discharges, while gain-of-function mutations were related to more severe epilepsy, developmental problems, ataxia, and brain atrophy. Patients with gain-and-loss-of-function mutations had the most severe early-onset phenotypes [2]. Two epilepsy-associated Kcna2 variants at position H310 had opposite effects on Kv1.2 functional expression. The p.H310Y variant caused “dual gain of function” by increasing cell-surface trafficking and activity and abolishing “ball and chain” inactivation, while the p.H310R variant led to “dual loss of function” by diminishing surface levels and inhibiting voltage-dependent channel opening [3].

In conclusion, Kcna2 is essential for regulating neuronal excitability. Studies on Kcna2-related mutations, especially through functional studies similar to those in KO/CKO mouse models, have revealed its role in various neurological diseases, particularly epileptic encephalopathy. Understanding Kcna2's functions provides insights into the mechanisms of these diseases, potentially guiding future therapeutic strategies [1,2,3].

References:

1. Xie, Changning, Kessi, Miriam, Yin, Fei, Peng, Jing. 2024. Roles of KCNA2 in Neurological Diseases: from Physiology to Pathology. In Molecular neurobiology, 61, 8491-8517. doi:10.1007/s12035-024-04120-9. https://pubmed.ncbi.nlm.nih.gov/38517617/

2. Masnada, Silvia, Hedrich, Ulrike B S, Gardella, Elena, Lerche, Holger, Rubboli, Guido. . Clinical spectrum and genotype-phenotype associations of KCNA2-related encephalopathies. In Brain : a journal of neurology, 140, 2337-2354. doi:10.1093/brain/awx184. https://pubmed.ncbi.nlm.nih.gov/29050392/

3. Mínguez-Viñas, Teresa, Prakash, Varsha, Wang, Kaiqian, Gunnarsson, Cecilia, Pantazis, Antonios. 2023. Two epilepsy-associated variants in KCNA2 (KV 1.2) at position H310 oppositely affect channel functional expression. In The Journal of physiology, 601, 5367-5389. doi:10.1113/JP285052. https://pubmed.ncbi.nlm.nih.gov/37883018/

4. Gao, Kai, Lin, Zehong, Wen, Sijia, Jiang, Yuwu. 2022. Potassium channels and epilepsy. In Acta neurologica Scandinavica, 146, 699-707. doi:10.1111/ane.13695. https://pubmed.ncbi.nlm.nih.gov/36225112/

Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest